ICU Medical Revenue 2006-2018 | ICUI

ICU Medical annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • ICU Medical revenue for the quarter ending September 30, 2018 was $0.327B, a 4.68% decline year-over-year.
  • ICU Medical revenue for the twelve months ending September 30, 2018 was $1.430B, a 40.43% increase year-over-year.
  • ICU Medical annual revenue for 2017 was $1.293B, a 240.72% increase from 2016.
  • ICU Medical annual revenue for 2016 was $0.379B, a 11.04% increase from 2015.
  • ICU Medical annual revenue for 2015 was $0.342B, a 10.48% increase from 2014.
ICU Medical Annual Revenue
(Millions of US $)
2017 $1,293
2016 $379
2015 $342
2014 $309
2013 $314
2012 $317
2011 $302
2010 $283
2009 $229
2008 $205
2007 $188
2006 $202
2005 $158
ICU Medical Quarterly Revenue
(Millions of US $)
Q3 2018 $327
Q2 2018 $360
Q1 2018 $372
Q4 2017 $370
Q3 2017 $343
Q2 2017 $332
Q1 2017 $248
Q4 2016 $96
Q3 2016 $97
Q2 2016 $97
Q1 2016 $90
Q4 2015 $90
Q3 2015 $86
Q2 2015 $84
Q1 2015 $81
Q4 2014 $80
Q3 2014 $77
Q2 2014 $79
Q1 2014 $73
Q4 2013 $78
Q3 2013 $83
Q2 2013 $79
Q1 2013 $74
Q4 2012 $83
Q3 2012 $81
Q2 2012 $77
Q1 2012 $76
Q4 2011 $76
Q3 2011 $76
Q2 2011 $78
Q1 2011 $71
Q4 2010 $74
Q3 2010 $76
Q2 2010 $69
Q1 2010 $64
Q4 2009 $67
Q3 2009 $54
Q2 2009 $53
Q1 2009 $54
Q4 2008 $57
Q3 2008 $55
Q2 2008 $49
Q1 2008 $45
Q4 2007 $46
Q3 2007 $45
Q2 2007 $49
Q1 2007 $49
Q4 2006 $53
Q3 2006 $49
Q2 2006 $51
Q1 2006 $49
Q4 2005 $43
Q3 2005 $47
Q2 2005 $41
Q1 2005 $27
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $5.184B $1.293B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.673B 26.23
Medtronic (MDT) Ireland $124.635B 18.20
Stryker (SYK) United States $69.927B 25.67
Boston Scientific (BSX) United States $55.591B 27.10
Baxter (BAX) United States $39.448B 24.31
Zimmer Biomet Holdings (ZBH) United States $25.289B 16.23
Smith & Nephew SNATS (SNN) United Kingdom $16.755B 0.00
ResMed (RMD) United States $14.297B 27.11
Canopy Growth (CGC) Canada $10.742B 0.00
Bio-Rad Laboratories (BIO) United States $8.172B 52.25
Aurora Cannabis (ACB) Canada $7.060B 50.50
Hill-Rom Holdings (HRC) United States $6.958B 21.52
Perrigo (PRGO) Ireland $6.649B 10.09
Insulet (PODD) United States $5.071B 0.00
Haemonetics (HAE) United States $4.540B 40.28
GW Pharmaceuticals (GWPH) United Kingdom $4.400B 0.00
Agios Pharmaceuticals (AGIO) United States $3.380B 0.00
Hutchison China MediTech (HCM) China $3.329B 0.00
Neogen (NEOG) United States $3.267B 50.18
NuVasive (NUVA) United States $2.850B 24.96
Quidel (QDEL) United States $2.761B 24.91
National Vision Holdings (EYE) United States $2.637B 51.01
Aphria (APHA) $2.539B 112.78
NxStage Medical (NXTM) United States $2.000B 0.00
AtriCure (ATRC) United States $1.274B 0.00
HEXO (HEXO) $1.242B 0.00
Cardiovascular Systems (CSII) United States $1.240B 890.25
Phibro Animal Health (PAHC) United States $1.220B 17.53
VAREX IMAGING (VREX) United States $1.212B 23.73
MacroGenics (MGNX) United States $0.939B 0.00
Cerus (CERS) United States $0.904B 0.00
PetIQ (PETQ) United States $0.867B 22.47
Lantheus Holdings (LNTH) United States $0.847B 22.95
Surmodics (SRDX) United States $0.785B 114.20
Meridian Bioscience (VIVO) United States $0.733B 21.85
NanoString Technologies (NSTG) United States $0.721B 0.00
OraSure Technologies (OSUR) United States $0.720B 31.76
Omeros (OMER) United States $0.719B 0.00
Evolus (EOLS) United States $0.705B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.647B 20.75
LeMaitre Vascular (LMAT) United States $0.603B 28.76
Quanterix (QTRX) United States $0.518B 0.00
Insys Therapeutics (INSY) United States $0.426B 0.00
Owens & Minor (OMI) United States $0.408B 5.65
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.329B 445.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.294B 0.00
Vapotherm (VAPO) United States $0.288B 0.00
Bovie Medical (APYX) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Zynex (ZYXI) United States $0.174B 16.84
Fonar (FONR) United States $0.144B 7.70
Surface Oncology (SURF) United States $0.140B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.084B 0.00
InfuSystems Holdings (INFU) United States $0.078B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.20
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Myomo (MYO) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14